These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33942574)

  • 1. A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity.
    Täubel J; Mazzetti A; Ferber G; Burch W; Fernandes S; Patel A; Spencer CS; Freier A; Graff C; Kanters JK; Camm J
    Clin Pharmacol Drug Dev; 2021 Jun; 10(6):572-581. PubMed ID: 33942574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):563. PubMed ID: 31251549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.
    Hebert A; Thiboutot D; Stein Gold L; Cartwright M; Gerloni M; Fragasso E; Mazzetti A
    JAMA Dermatol; 2020 Jun; 156(6):621-630. PubMed ID: 32320027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro.
    Rosette C; Rosette N; Mazzetti A; Moro L; Gerloni M
    J Drugs Dermatol; 2019 Feb; 18(2):197-201. PubMed ID: 30811143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clascoterone: First Approval.
    Dhillon S
    Drugs; 2020 Nov; 80(16):1745-1750. PubMed ID: 33030710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream.
    Trifu V; Tiplica GS; Naumescu E; Zalupca L; Moro L; Celasco G
    Br J Dermatol; 2011 Jul; 165(1):177-83. PubMed ID: 21428978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clascoterone cream (1%) topical androgen receptor inhibitor for the treatment of acne in patients 12 years and older.
    Gold M
    Expert Rev Clin Immunol; 2021 Apr; 17(4):301-308. PubMed ID: 33616473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro.
    Rosette C; Agan FJ; Mazzetti A; Moro L; Gerloni M
    J Drugs Dermatol; 2019 May; 18(5):412-418. PubMed ID: 31141847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full spectroscopic characterization of two crystal pseudopolymorphic forms of the antiandrogen cortexolone 17α-propionate for topic application.
    Ferraboschi P; Chiara Sala M; Stradi R; Ragonesi L; Gagliardi C; Lanzarotti P; Ragg EM; Mori M; Meneghetti F
    Steroids; 2017 Dec; 128():95-104. PubMed ID: 28923714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% twice daily, in patients with acne vulgaris.
    Eichenfield L; Hebert A; Gold LS; Cartwright M; Fragasso E; Moro L; Mazzetti A
    J Am Acad Dermatol; 2020 Aug; 83(2):477-485. PubMed ID: 32348828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vitro Skin Permeation of Clascoterone From Clascoterone Topical Cream, 1% (w/w).
    Yang Y; Wang J; Wanasathop A; Niu M; Ghosh P; Zidan A; Gu J; Hunt R; Faustino P; Ashraf M; Xu X
    AAPS PharmSciTech; 2024 Aug; 25(6):186. PubMed ID: 39138712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological profile of cortexolone 17alpha-propionate (CB-03-01), a new topical and peripherally selective androgen antagonist.
    Celasco G; Moro L; Bozzella R; Ferraboschi P; Bartorelli L; Quattrocchi C; Nicoletti F
    Arzneimittelforschung; 2004; 54(12):881-6. PubMed ID: 15646372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clascoterone for treatment of acne.
    Manjaly C; Martinez J; Barbieri J; Mostaghimi A
    Drugs Today (Barc); 2023 Feb; 59(2):71-81. PubMed ID: 36811407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne.
    Peterson H; Kircik L; Armstrong AW
    J Drugs Dermatol; 2023 Jun; 22(6):SF350992s7-SF350992s14. PubMed ID: 37276168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Alkhodaidi ST; Al Hawsawi KA; Alkhudaidi IT; Magzoub D; Abu-Zaid A
    Dermatol Ther; 2021 Jan; 34(1):e14609. PubMed ID: 33258536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-Pituitary-Adrenal Axis Response in Patients With Acne Vulgaris Treated With Clascoterone.
    Bhatia N; Eichenfield LF; Mazzetti A; Moro L; Squittieri N; Hebert AA
    J Drugs Dermatol; 2024 Jun; 23(6):433-437. PubMed ID: 38834220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortexolone 17α-propionate for hidradenitis suppurativa.
    Der Sarkissian SA; Sun HY; Sebaratnam DF
    Dermatol Ther; 2020 Nov; 33(6):e14142. PubMed ID: 32761708
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
    Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clascoterone: A Novel Topical Androgen Receptor Inhibitor for the Treatment of Acne.
    Kalabalik-Hoganson J; Frey KM; Ozdener-Poyraz AE; Slugocki M
    Ann Pharmacother; 2021 Oct; 55(10):1290-1296. PubMed ID: 33533262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.